<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="AsOf2025-09-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001460702</identifier>
        </entity>
        <period>
            <startDate>2025-09-16</startDate>
            <endDate>2025-09-16</endDate>
        </period>
    </context>
    <context id="From2025-09-162025-09-16_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001460702</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-16</startDate>
            <endDate>2025-09-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-16" id="Fact000003">0001460702</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="AsOf2025-09-16" id="xdx2ixbrl0009">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:FormTp contextRef="AsOf2025-09-16" id="Fact000010">S-1</ffd:FormTp>
    <ffd:SubmissnTp contextRef="AsOf2025-09-16" id="Fact000011">S-1</ffd:SubmissnTp>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-16" id="Fact000012">Qualigen Therapeutics, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="From2025-09-162025-09-16_1" id="Fact000013">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="From2025-09-162025-09-16_1" id="Fact000014">Common stock, $0.001 par value per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="From2025-09-162025-09-16_1" id="Fact000020">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="From2025-09-162025-09-16_1"
      decimals="INF"
      id="Fact000015"
      unitRef="Shares">3214292</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="From2025-09-162025-09-16_1"
      decimals="INF"
      id="Fact000016"
      unitRef="USDPShares">1.73</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="From2025-09-162025-09-16_1"
      decimals="INF"
      id="Fact000017"
      unitRef="USD">5560725.16</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="From2025-09-162025-09-16_1"
      decimals="INF"
      id="Fact000018"
      unitRef="Ratio">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="From2025-09-162025-09-16_1"
      decimals="INF"
      id="Fact000019"
      unitRef="USD">851.35</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="AsOf2025-09-16"
      decimals="INF"
      id="Fact000021"
      unitRef="USD">5560725.16</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="AsOf2025-09-16"
      decimals="INF"
      id="Fact000022"
      unitRef="USD">851.35</ffd:TtlFeeAmt>
    <ffd:PrevslyPdFlg contextRef="From2025-09-162025-09-16_1" id="Fact000023">false</ffd:PrevslyPdFlg>
    <ffd:TtlPrevslyPdAmt
      contextRef="AsOf2025-09-16"
      decimals="INF"
      id="Fact000024"
      unitRef="USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="AsOf2025-09-16"
      decimals="INF"
      id="Fact000025"
      unitRef="USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="AsOf2025-09-16"
      decimals="INF"
      id="Fact000026"
      unitRef="USD">851.35</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="From2025-09-162025-09-16_1" id="Fact000028">Represents
    the number of shares of common stock, par value $0.001 per share (&#x201c;Common Stock&#x201d;) of Qualigen Therapeutics, Inc. that
    will be offered for resale by the selling stockholders named in this registration statement (the &#x201c;Registration Statement&#x201d;).
    Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), the Registration Statement
    shall also cover any additional shares of Common Stock that become issuable by reason of any stock dividend, stock split, recapitalization
    or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common
    Stock.Estimated
    solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act, based on
    the average of the high and low sales price of the Common Stock as reported on The Nasdaq Capital Market on September 8, 2025, a
    date within five business days prior to the filing of the Registration Statement. </ffd:OfferingNote>
    <ffd:OffsetTableNa contextRef="AsOf2025-09-16" id="Fact000029">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="AsOf2025-09-16" id="Fact000030">N/A</ffd:CombinedProspectusTableNa>
</xbrl>
